Kanabo Group Plc (LON: KNB)

Market Cap	5.69M
Revenue (ttm)	1.14M
Net Income (ttm)	-8.18M
Shares Out	632.43M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	66,194
Open	1.044
Previous Close	1.000
Day's Range	0.900 - 1.100
52-Week Range	0.900 - 3.200
Beta	3.04
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Kanabo Group

Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain. It also provides cultivation consultancy for cannabis businesses, as well...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2016
• Employees: 20
• Stock Exchange: London Stock Exchange
• Ticker Symbol: KNB

Financial Performance

In 2023, Kanabo Group's revenue was 895,000, an increase of 48.42% compared to the previous year's 603,000. Losses were -7.99 million, 16.3% more than in 2022.